SATORICELL

Why what is in this bottle is not elsewhere

Ingredient lists have barely changed in twenty years. Not because better molecules do not exist, but because they are hard to find and expensive to make. This page is about getting around both.

The industry cannot invent new ingredients, and cannot afford the ones it has

360 GB

All the ground-truth data the field holds on how an ingredient acts on skin. Less than one phone, so discovery stays trial and error.

$2,000 / kg

What a kilogram of collagen or peptide costs the industry to make today. So a brand doses a trace amount: it is on the label, not on the skin.

So nothing changes. Brands recycle the same twenty-year-old ingredients and compete on marketing instead of results.

One system does both jobs: AI picks the molecule, microalgae make it

Finding what to make

  1. 01

    Human interactome data

    The first interactome database built to train an AI cell model

  2. 02

    Whole-genome-edited cell library

    Wet-lab work confirming which protein is really involved in ageing

  3. 03

    AI screening

    Predicting which chemicals and peptides bind the target protein

  4. 04

    MagTech lifespan screen

    Our own method for finding, quickly, which molecules extend a single cell's lifespan

Making it

  1. 01

    Algae interactome data

    The same data foundation, for the algal cell

  2. 02

    Algae cell model

    Finding which master regulator controls a given synthesis

  3. 03

    Algae factory

    The cell makes the molecule itself; the inputs are sunlight and water

  4. 04

    Delivery into skin

    AI-designed lipid nanoparticles. Before these, there was no working route into skin for such a molecule

Letting the algal cell do the synthesis brings a kilogram of active peptide down to a twentieth of the industry price, so the constraint above, that a brand can only afford a trace amount, stops applying. Anyone can buy an AI model. Having the data, the synthetic biology, the factory and the delivery inside one company is a different matter.

Not a lab project

Bench and a 100-litre pilot are both done; commercial scale is next. What follows can be checked.

100-litre pilot
Bench and pilot both complete
18 papers in 3 years
Published and in submission
10+ patents filed
Marine actives and peptide sequences
ISO 22716 · GMP
Cosmetic manufacturing quality
SGS · Intertek
Third-party testing
Institute of Dermatology, CAMS
28-day clinical partner, N=120
Safety assessment complete
Substantiated and on file, as MoCRA requires
Cell and skin testing complete
Irritation and tolerance testing before sale

All of this ends up as one serum.

See the serumMeet the people

This page describes the laboratory's research methods and capacity. It is not a promise about what the product does. The product is a cosmetic, not a drug: it does not diagnose, treat, cure or prevent any condition, and results vary between individuals.

Does any of it work?

A method for finding and making a molecule is not evidence that the molecule does anything. These pages take that question separately, from published research rather than from our own product — including where the evidence is weaker than the marketing.